Other top stories

Controversy Surrounds Brexpiprazole's FDA Approval, a New Alzheimer's Agitation Drug

August 21, 2023

The Weekly Mind Reader: Laughing Gas for Suicide Prevention

August 18, 2023

Point of View: Not All Borderline Personality Disorder is Alike

August 17, 2023

Why Clozapine is Still an Essential Antipsychotic

August 16, 2023

New Research Links Dirty Air from Wildfires to Higher Dementia Risk

August 15, 2023

Suicide Mortality Spiked 48% in 20 Years, New CDC Data Shows

August 14, 2023

Other stories

The Weekly Mind Reader: The Cost of Schizophrenia Exceeds $170 Billion Annually

August 11, 2023

Long-Term Use of Some Acid Reflux Drugs Linked to 33% Higher Dementia Risk

August 10, 2023

New Consensus Guidelines Offer a Roadmap for Digital Mental Health Services

August 9, 2023

3 Ways ADHD Makes Romantic Relationships More Challenging

August 8, 2023

Antidepressant-Resistant Depression Biotype Identified in 27% of Study Patients

August 7, 2023

The Weekly Mind Reader: Antihypertensive Drugs and PTSD

August 4, 2023

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe